Publications and communications of Jean-Paul Chapelle

LE GOFF, C., Kaux, J.-F., D'OTREPPE DE BOUVETTE, S., Goffaux, S., Fillet, M., Chapelle, J.-P., & Cavalier, E. (August 2016). Release of cardiac biomarkers during a cycling race. World Journal of Cardiovascular Diseases, 6 (8), 285-294.

DE SENY, D., COBRAIVILLE, G., CHARLIER, E., NEUVILLE, S., LUTTERI, L., LE GOFF, C., MALAISE, D., MALAISE, O., CHAPELLE, J.-P., RELIC, B., & MALAISE, M. (2015). Apolipoprotein-A1 as a damage-associated molecular patterns protein in osteoarthritis: ex vivo and in vitro pro-inflammatory properties. PLoS ONE. doi:10.1371/journal.pone.0122904

Streel, S.* , Donneau, A.-F.* , Hoge, A., Majerus, S., KOLH, P., CHAPELLE, J.-P., Albert, A., & Guillaume, M. (2015). Socioeconomic impact on the prevalence of cardiovascular risk factors in Wallonia, Belgium: a population based-study. BioMed Research International, 1-10. doi:10.1155/2015/580849
* These authors have contributed equally to this work.

LE GOFF, C., Kaux, J.-F., LAURENT, T., Vannuscorps, J., PINCEMAIL, J., Chapelle, J.-P., Cavalier, E., & Croisier, J.-L. (May 2014). Is isokinetic eccentric exercise dangerous for the heart? Isokinetics and Exercise Science, 22 (2), 131-136. doi:10.3233/IES-130529

LE GOFF, C., Kaux, J.-F., Leroy, L., PINCEMAIL, J., Chapelle, J.-P., & Cavalier, E. (September 2013). Fatty acids and associated cardiovascular risk. Food and Nutrition Sciences, 4 (9A), 188-194.

LE GOFF, C., Kaux, J.-F., MELON, P., Fillet, M., CHAPELLE, J.-P., & Cavalier, E. (September 2013). Running races: study of the stress and cardiac biomarkers. European Journal of Sports Medicine, 1 (Supplement 1), 212.

LE GOFF, C., MELON, P., BREVERS, E., Fillet, M., Kaux, J.-F., Chapelle, J.-P., & Cavalier, E. (2013). Comparison of the Heart-type fatty acid-binding protein (H-FABP) with the high sensitive cardiac troponin T in healthy runners. In Book of abstracts of 18th Annual Congress of the ECSS (pp. 465).

LE GOFF, C., Kaux, J.-F., BREVERS, E., Fillet, M., MELON, P., CHAPELLE, J.-P., & Cavalier, E. (May 2013). Comparison of the Heart-type fatty acid-binding protein (H-FABP) with the high sensitive cardiac troponin T in healthy runners. Biochimica Clinica, 37 (SS), 544.

LE GOFF, C., Kaux, J.-F., MELON, P., Fillet, M., CHAPELLE, J.-P., & Cavalier, E. (May 2013). Race Cycling: biological evolution. Biochimica Clinica, 37 (SS), 544.

LE GOFF, C., MELON, P., Kaux, J.-F., Fillet, M., CHAPELLE, J.-P., & Cavalier, E. (May 2013). Impact of strenuous exercise on the release of cardiac biomarkers. Biochimica Clinica, 37 (SS), 545.

LE GOFF, C., Kaux, J.-F., Leroy, L., Cavalier, E., & Chapelle, J.-P. (October 2012). Le dosage des acides gras érythrocytaires : comparaison entre une population de référence et des sujets ayant présenté un infarctus aigu du myocarde. Immuno-Analyse and Biologie Spécialisée, 27 (5), 237-243. doi:10.1016/j.immbio.2012.04.003

HAMDI, E., DELANAYE, P., LUTTERI, L., CHAPELLE, J.-P., & CAVALIER, E. (18 July 2012). analytical and Clinical Validation of Beta-Trace Protein, a New Marker of Glomerular Filtration Rate [Poster presentation]. AACC 2012, Los Angeles, United States.

CAVALIER, E., CARLISI, I., FERRANTE, N., BEKAERT, A.-C., ROUSSELLE, O., & CHAPELLE, J.-P. (17 July 2012). Analytical Performance of the IDS-iSYS CROSSLAPS (CTX-I) Automated Immunoassay [Poster presentation]. AACC 2012, Los Angeles, United States.

CAVALIER, E., CARLISI, I., FERRANTE, N., ROUSSELLE, O., & CHAPELLE, J.-P. (17 July 2012). Evaluation of the Liaison 25-OH Vitamin D TOTAL Assay on the new DiaSorin Liaison XL [Poster presentation]. AACC 2012, Los Angeles, United States.

CAVALIER, E., CARLISI, I., FERRANTE, N., ROUSSELLE, O., CHAPELLE, J.-P., & DELANAYE, P. (17 July 2012). Evaluation of Sclerostin levels in patients suffering from Chronic Kidney Diseases [Poster presentation]. AACC 2012, Los Angeles, United States.

CAVALIER, E., CARLISI, I., MEURISSE, A., FERRANTE, N., ROUSSELLE, O., & CHAPELLE, J.-P. (17 July 2012). Analytical Verification of the IDS-iSYS Intact Amino-terminal Propeptide of Type 1 Procollagen (P1NP) [Poster presentation]. AACC 2012, Los Angeles, United States.

LE GOFF, C., PEETERS, S., CRINE, Y., LUKAS, P., CHAPELLE, J.-P., & CAVALIER, E. (17 July 2012). Evaluation of the Cross-reactivity of 25-Hydroxy-vitamin D2 on Six Commercial Immunoassays on Native Samples [Poster presentation]. AACC 2012, Los Angeles, United States.

LE GOFF, C., PEETERS, S., CRINE, Y., LUKAS, P., CHAPELLE, J.-P., & CAVALIER, E. (17 July 2012). Analytical validation of the Perkin-Elmer MSMS Vit D for 25-Hydroxy-vitamin D determination on AB SCIEX TQ5500 [Poster presentation]. AACC 2012, Los Angeles, United States.

LE GOFF, C., Kaux, J.-F., Goffaux, S., MELON, P., Fillet, M., & Chapelle, J.-P. (2012). Biological variations during a race cycling. In Biomedica 2012 (pp. 157).

LE GOFF, C., LAURENT, T., GARWEG, C., Kaux, J.-F., HALENG, J., Charlier, C., & Chapelle, J.-P. (February 2012). Apport des troponines T et I ultrasensibles dans le diabète. Immuno-Analyse and Biologie Spécialisée, 27 (1), 40.

LE GOFF, C., Leroy, L., Kaux, J.-F., CAVALIER, E., & Chapelle, J.-P. (February 2012). Le dosage des acides gras érythrocytaires : comparaison entre une population de référence et des sujets ayant présenté un infarctus aigu du myocarde [Poster presentation]. 28e Colloque IBS CORATA, Namur, Belgium.

FAILLA, V., CAVALIER, E., EL HAYDERI, L., PAUROBALLY, D., Chapelle, J.-P., DEZFOULIAN, B., & NIKKELS, A. (2012). Seasonal variations in vitamin D levels in melanoma patients: a single-centre prospective pilot comparative study. Journal of the European Academy of Dermatology and Venereology, 26 (5), 651-3. doi:10.1111/j.1468-3083.2011.04087.x

LE GOFF, C., LAURENT, T., Kaux, J.-F., & Chapelle, J.-P. (January 2012). Intense physical exercise related to the emergent generation of cardiovascular risk markers: a review. Biology of Sport, 29 (1), 11-16. doi:10.5604/20831862.979290

TEIXEIRA, J., Guillaume, M., NELLESSEN, E., & Chapelle, J.-P. (2012). BNP et NT-proBNP: valeurs de référence et seuils décisionnels. Revue Médicale de Liège, 67 (1), 38-43.

RADERMECKER, R., CHAPELLE, J.-P., PAQUOT, N., & Thielen, V. (December 2011). Undetectable HbA1c in a type 2 diabetic woman: Case report of a rare haemoglobin variant [Poster presentation]. International diabetes federation IDF 2011, World Diabetes Congress, Dubai, United Arab Emirates.

DE BACKER, B., Poncin, J., HALENG, J., CHAPELLE, J.-P., & CAVALIER, E. (15 October 2011). Comparison between the new AccuChek Inform II glucose meter and the Rapidlab 865 blood gas analyzer: implications for use of the Inform II in tight glycemic control [Poster presentation]. BVKB - SBBC (Belgian Society for Clinical Biology) Annual Symposium 2011, Liège, Belgium.

TEIXEIRA, J., WOTQUENNE, P., D'ORIO, V., Gruson, D., & Chapelle, J.-P. (15 October 2011). Early assessment of myocardial injury by joint measurement of TnT-hs and Copeptin [Poster presentation]. BVKB-SBBC Annual Meeting - The Future of Clinical Biology, Liège, Belgium.

CAVALIER, E., BEKAERT, A.-C., CARLISI, I., & CHAPELLE, J.-P. (17 September 2011). Automated Measurement of Total 25OH Vitamin D in the IDS iSYS System [Poster presentation]. ASBMR 2011 Annual Meeting, San-Diego, United States.

LE GOFF, C., Kaux, J.-F., GARWEG, C., LAURENT, T., Vannuscorp, J., Rodriguez de la Cruz, C., Bury, T., & Chapelle, J.-P. (2011). La troponine T ultrasensible : un nouvel outil diagnostic pour le médecin sportif? In 4ème Congrès commun SFMS & SFTS (pp. 87-88).

CAVALIER, E., CARLISI, I., BEKAERT, A.-C., GUADAGNI, A., ROUSSELLE, O., CHAPELLE, J.-P., & DELANAYE, P. (28 July 2011). New insights on the stability of the (1-84) PTH as determined with an automated 3rd generation PTH assay [Poster presentation]. AACC, Atlanta, United States.

CAVALIER, E., DELANAYE, P., Vranken, L., CARLISI, I., BEKAERT, A.-C., CHAPELLE, J.-P., & Souberbielle, J.-C. (28 July 2011). Impact of the use of the Manufacturer's published reference range for PTH vs. the reference range established in the Laboratory for the classification of the haemodialyzed patients with the KDIGO Guidelines [Poster presentation]. AACC, Atlanta, United States.

CAVALIER, E., PONCIN, J., MUSSO, G., HALENG, J., & CHAPELLE, J.-P. (27 July 2011). Analytical validation of Accu-check Inform II meters and strips before their use in the wards: practical experience of the CHU de Liège [Poster presentation]. AACC 2011, Atlanta, United States.

LE GOFF, C., Bury, T., Rodriguez de la Cruz, C., Kaux, J.-F., Vannuscorps, J., Chapelle, J.-P., & Croisier, J.-L. (May 2011). Elevation of cardiac and oxidative stress biomarkers after a running activity in sedentary subjects. Clinical Chemistry and Laboratory Medicine, 49 (Special Suppl), 313.

LE GOFF, C., GARWEG, C., Kaux, J.-F., MELON, P., LANCELLOTTI, P., Pierard, L., & Chapelle, J.-P. (May 2011). Use of a novel high-sensitivity troponin T, I and MPO, NT-proBNP assays to detect myocardial injury in patients with atrial fibrillation treated by direct-current cardioversion. Clinical Chemistry and Laboratory Medicine, 49 (Special Suppl), 312.

LE GOFF, C., Leroy, L., Kaux, J.-F., CAVALIER, E., & Chapelle, J.-P. (May 2011). Fatty acids and cardiovascular risk. Clinical Chemistry and Laboratory Medicine, 49 (Special Suppl), 313.

Cavalier, E., Huberty, V., Carlisi, I., Chapelle, J.-P., Vroonen, L., & Beckers, A. (18 March 2011). Human anti-animal antibodies interference in the Siemens Immulite chemiluminescent insulin immuno-assay: about one case. Clinica Chimica Acta, 412 (7-8), 668-669. doi:10.1016/j.cca.2010.12.035

PAQUOT, N., PINCEMAIL, J., cillard, J., Hininger, I., Luliano, L., Cazaubiel, M., Guerard, F., CHAPELLE, J.-P., CHARLIER, C., & DEFRAIGNE, J. (March 2011). Effets d’un apport accru en fruits et légumes sur 9 marqueurs de la peroxydation lipidique chez des sujets diabétiques de type 2. Diabète et Métabolisme, 37, 38.

CAVALIER, E., CARLISI, I., BEKAERT, A.-C., CHAPELLE, J.-P., & SOUBERBIELLE, J.-C. (2011). Validation of the Abbott Architect 25(OH)-vitamin D assay. Clinical Chemistry and Laboratory Medicine, 49 (s1), 418.

Cavalier, E., Carlisi, I., Bekaert, A.-C., Rousselle, O., Chapelle, J.-P., & Delanaye, P. (2011). Analytical validation of the Liaison Calcitonin_II-Gen (DiaSorin). Clinical Chemistry and Laboratory Medicine, 49 (2), 271-275. doi:10.1515/CCLM.2011.036

Gadisseur, R., Chapelle, J.-P., & Cavalier, E. (2011). A new tool in the field of in-vitro diagnosis of allergy: preliminary results in the comparison of ImmunoCAP (c) 250 with the ImmunoCAP (c) ISAC. Clinical Chemistry and Laboratory Medicine, 49 (2), 277-80. doi:10.1515/CCLM.2011.052

PAQUOT, N., PINCEMAIL, J., Cillard, J., Hininger, I., Luliano, L., Cauzaubiel, M., Guerard, F., CHAPELLE, J.-P., CHARLIER, C., & Defraigne, J.-O. (2011). Effets d’un accroissement en fruits et légumes sur neuf marqueurs de la peroxydation lipidique chez des sujets diabétiques de type 2. Diabète et Métabolisme, 37 (suppl 1), 38.

PINCEMAIL, J., Vanbelle, S., Degrune, F., CHERAMY-BIEN, J.-P., CHARLIER, C., Chapelle, J.-P., Giet, D., Collette, G., Albert, A., & Defraigne, J.-O. (2011). Lifestyle Behaviours and Plasma Vitamin C and β-Carotene Levels from ELAN Population (Liège, Belgium). Journal of Nutrition and Metabolism, 2011. doi:10.1155/2011/494370

Gadisseur, R., Chapelle, J.-P., & Cavalier, E. (18 November 2010). Analyse morphoconstitutionnelle des lithiases [Paper presentation]. GLEM de Biologie Clinique, Fléron, Belgium.

Gadisseur, R., Chapelle, J.-P., & Cavalier, E. (October 2010). New technologies in allergology, Workshop [Paper presentation]. Symposium BVKB/SBBC, Anvers, Belgium.

Cavalier, E., Daly, A., Betea, D., Pruteanu-Apetrii, P. N., Delanaye, P., Stubbs, P., Bradwell, A. R., Chapelle, J.-P., & Beckers, A. (August 2010). The Ratio of Parathyroid Hormone as Measured by Third- and Second-Generation Assays as a Marker for Parathyroid Carcinoma. Journal of Clinical Endocrinology and Metabolism, 95, 3745-9. doi:10.1210/jc.2009-2791

Keutgens, A., Shostak, K., Close, P., Zhang-Shao, X., Hennuy, B., Aussems, M., Chapelle, J.-P., Viatour, P., Gothot, A., Fillet, M., & Chariot, A. (August 2010). The repressing function of the oncoprotein BCL-3 requires CtBP while its polyubiquitination and degradation involve the E3 ligase TBLR1. Molecular and Cellular Biology, 30, 4006-4021. doi:10.1128/MCB.01600-09

Le Goff, C., Garweg, C., Laurent, T., Kaux, J.-F., Deroyer, C., Merville, M.-P., Melon, P., Fillet, M., Legrand, V., & Chapelle, J.-P. (July 2010). Assessment of high sensitive troponin T and I immunoassays in patients with acute chest. Clinical Chemistry, 56 (S6), 127.

Le Goff, C., Laurent, T., Garweg, C., Kaux, J.-F., Deroyer, C., Fillet, M., Lancellotti, P., Pierard, L., & Chapelle, J.-P. (July 2010). Does echocardiographic stress test induced release of hsTnT and TnI II? Clinical Chemistry, 56 (S6), 128.

Cavalier, E., Carlisi, I., Bekaert, A.-C., Rousselle, O., Delanaye, P., & Chapelle, J.-P. (June 2010). Evaluation of Liaison Calcitonin II Gen, a new kit for Calcitonin determination. Clinical Chemistry, 56 (S6), 188.

Cavalier, E., Daly, A., Betea, D., Pruteanu Apetrii, P., Delanaye, P., Stubbs, P., Bradwell, A. R., Chapelle, J.-P., & Beckers, A. (June 2010). The ratio of PTH as measured by third and second generation assays as a marker for parathyroid carcinoma. Clinical Chemistry, 56 (S6), 188.

Cavalier, E., Rousselle, O., Bekaert, A.-C., Carlisi, I., Chapelle, J.-P., & Delanaye, P. (June 2010). Evaluation of the DiaSorin Liaison 1-84 PTH Assay, a new automated immunoassay for the determination of the 3rd Generation PTH. Clinical Chemistry, 56 (S6), 56.

Cavalier, E., Saarbach, D., Bekaert, A.-C., Carlisi, I., Chapelle, J.-P., & Delanaye, P. (June 2010). Analytical validation of the Abbott Architect urine NGAL. Clinical Chemistry, 56 (S6), 96.

Close, P., Creppe, C., Gillard, M., LADANG, A., Chapelle, J.-P., Nguyen, L., & Chariot, A. (April 2010). The emerging role of lysine acetylation of non-nuclear proteins. Cellular and Molecular Life Sciences, 67 (8), 1255-1264. doi:10.1007/s00018-009-0252-7

Le Goff, C., Laurent, T., Chapelle, J.-P., & Kaux, J.-F. (20 March 2010). Release of cardiac biomarkers after an intense physical exercise: preliminary results [Poster presentation]. VVS Biennial Congress for Sports Medicine and Sports Sciences, Brugge, Belgium.

Le Goff, C., Kaux, J.-F., Bovy, C., Da Silva, A., & Chapelle, J.-P. (March 2010). Comparaison des taux de BNP et de NT-proBNP chez des patients insuffisants rénaux pour prévenir l'insuffisance cardiaque. Biotribune Magazine, 34, 6-9. doi:10.1007/s11834-010-0004-x

Gadisseur, R., Chapelle, J.-P., & Cavalier, E. (2010). Component-resolved-diagnosis and validation of an allergen-microarray technology. Allergy, 65 (suppl. 92), 93.

Gadisseur, R., Chapelle, J.-P., Cavalier, E., & Blanco-Catafal Anna, U. O. B. (Other coll.). (2010). Component-resolved diagnosis in peanut and hazelnut allergy. Allergy, 65 (Suppl.92), 106.

Ho, T. T. G., Keutgens, A., Chapelle, J.-P., & Cavalier, E. (2010). Corrélation aldostérone et parathormone en cas d'hyperparathyroïdie primaire vs secondaire? Annales de Biologie Clinique, 68 (6), 703-4.

Keutgens, A., Zhang-Shao, X., Shostak, K., Robert, I., Olivier, S., Vanderplasschen, A., Chapelle, J.-P., Viatour, P., Merville, M.-P., Bex, F., Gothot, A., & Chariot, A. (2010). BCL-3 degradation involves its polyubiquitination through a FBW7-independent pathway and its binding to the proteasome subunit PSMB1. Journal of Biological Chemistry, 285 (33), 25831–25840. doi:10.1074/jbc.M110.112128

Gadisseur, R., Chapelle, J.-P., & Cavalier, E. (19 November 2009). IMMUNOCAP© ISAC: INTEREST IN ALLERGY DIAGNOSIS [Poster presentation]. Symposium BVKB/SBBC, Mont-Godinne, Belgium.

Gadisseur, R., Chapelle, J.-P., & Cavalier, E. (19 November 2009). CRD and technical validation of ImmunoCAPISAC [Paper presentation]. ImmunoCAP ISAC : First International Users Meeting, Diegem, Belgium.

Le Goff, C., Kaux, J.-F., Denooz, A., & Chapelle, J.-P. (03 November 2009). Myéloperoxydase, LDL oxydées et anticorps anti-LDL oxydées sont-ils interdépendants ? [Poster presentation]. 54ème Edition des Journées Internationales de Biologie, Paris, France.

Le Goff, C., Kaux, J.-F., Denooz, A., & Chapelle, J.-P. (03 November 2009). Cholestérol total, HDL, LDL et LDL oxydées : implications cardiovasculaires [Poster presentation]. 54ème Edition des Journées Internationales de Biologie, Paris, France.

Gach, O., Louis, O., Chapelle, J.-P., Vanbelle, S., Pierard, L., & Legrand, V. (July 2009). Baseline inflammation is not predictive of periprocedural troponin elevation after elective percutaneous coronary intervention. Heart and Vessels, 24 (4), 267-70. doi:10.1007/s00380-008-1120-3

Cavalier, E., Carlisi, I., Chapelle, J.-P., & Rozet, E. (June 2009). VALIDATION AND ACCURACY PROFILES OF THE LIAISON BAP_OSTASE (DIASORIN), A NEW METHOD FOR THE DETERMINATION OF BONE ALKALINE PHOSPHATASE. Clinical Chemistry and Laboratory Medicine, 47 (51).

Cavalier, E., Rozet, E., Carlisi, I., Bekaert, A.-C., Chapelle, J.-P., & Delanaye, P. (June 2009). ANALYTICAL PERFORMANCE OF THE C-TERMINAL FGF-23 (IMMUTOPICS). Clinical Chemistry and Laboratory Medicine, 47 (M-A032).

Gadisseur, R., Chapelle, J.-P., & Cavalier, E. (June 2009). A new diagnostic tool for in vitro allergy. Allergy, 64, 30-31.

Gadisseur, R., Chapelle, J.-P., & Cavalier, E. (29 May 2009). Nouveaux outils de diagnostic in-vitro des allergies [Paper presentation]. Symposium CPALF, Mont-Godinne, Belgium.

Robert, I., Aussems, M., Keutgens, A., Zhang-Shao, X., Hennuy, B., Viatour, P., Vanstraelen, G., Merville, M.-P., Chapelle, J.-P., de Leval, L., LAMBERT, F., Dejardin, E., Gothot, A., & Chariot, A. (02 April 2009). Matrix Metalloproteinase-9 gene induction by a truncated oncogenic NF-κB2 protein involves the recruitment of MLL1 and MLL2 H3K4 histone methyltransferase complexes. Oncogene, 28 (13), 1626-1638. doi:10.1038/onc.2009.6

Gadisseur, R., Chapelle, J.-P., & Cavalier, E. (24 March 2009). Intérêt des allergènes recombinants: aspects biologiques [Paper presentation]. Jeudis de Fleurus, Haute Ecole Louvain en Hainaut, Fleurus, Belgium.

Cavalier, E., Carlisi, I., Chapelle, J.-P., Orfanos, P., Uzan, M., Falque, V., Delanaye, P., & Hachicha, M. (2009). Human anti-mouse antibodies interferences in Elecsys PTH assay after OKT3 treatment. Transplantation, 87 (3), 451-2. doi:10.1097/TP.0b013e31819575a1

Cavalier, E., Delanaye, P., Carlisi, I., Chapelle, J.-P., & Collette, J. (2009). An unusual interference in parathormone assay caused by anti-goat IgG: a case report. Clinical Chemistry and Laboratory Medicine, 47 (1), 118. doi:10.1515/CCLM.2009.015

Cavalier, E., Delanaye, P., Chapelle, J.-P., & Souberbielle, J.-C. (2009). Vitamin D: current status and perspectives. Clinical Chemistry and Laboratory Medicine, 47 (2), 120-127. doi:10.1515/CCLM.2009.036

De Bock, M., De Seny, D., Meuwis, M.-A., Chapelle, J.-P., Louis, E., Malaise, M., Merville, M.-P., & Fillet, M. (2009). Challenges for Biomarker Discovery in Body Fluids Using SELDI-TOF-MS. Journal of Biomedicine and Biotechnology. doi:10.1155/2010/906082

Gadisseur, R., Cataldo, D., Collard, L., Chapelle, J.-P., & Cavalier, E. (2009). Allergie au venin d'hyménoptère et tests de laboratoires : de nouvelles approches pour la prise en charge des patients à haut risque de réaction sévère. Revue Médicale de Liège, 64 (11), 570-5.

Le Goff, C., Bovy, C., Da Silva, A., Krzesinski, J.-M., & Chapelle, J.-P. (2009). Comparison of BNP and NT-proBNP performances for assessing heart failure in a population of patients with high incidence of with renal insufficiency. Annales de Biologie Clinique, 67 (1).

Le Goff, C., Haleng, J., & Chapelle, J.-P. (2009). Comparison of two immunoassays for quantitative measurement of oxydized-LDL. Immuno-Analyse and Biologie Spécialisée, 24, 183.

Le Goff, C., Haleng, J., Denooz, A., & Chapelle, J.-P. (2009). Comparison of two immunoassays for oxidized LDL determination. Annales de Biologie Clinique, 67 (1).

Mistretta, V., Cavalier, E., Collette, J., & Chapelle, J.-P. (2009). Production des anticorps monoclonaux. Revue Médicale de Liège, 64 (5-6), 248-252.

Mistretta, V., Cavalier, E., Collette, J., Lutteri, L., & Chapelle, J.-P. (2009). Intérêt des anticorps monoclonaux dans le laboratoire d'analyses biomédicales. Revue Médicale de Liège, 64 (5-6), 257-263.

Cavalier, E., Péroni, L., Abshoff, C., Lutteri, L., Chapelle, J.-P., Krzesinski, J.-M., & Delanaye, P. (November 2008). Etude analytique des trois trousses de cystatine C et impact sur les formules basées sur la cystatine pour l'estimation du DFG. Néphrologie et Thérapeutique, 4 (6), 399-400.

Cavalier, E., Delanaye, P., Carlisi, I., & Chapelle, J.-P. (September 2008). Analytical Validation of Diasorin Liaison and Roche Elecsys Methods for the Determination of Osteocalcin. Journal of Bone and Mineral Research, 23, 191.

Cavalier, E., Wallace, A. M., Knox, S., Mistretta, V., Chapelle, J.-P., & Souberbielle, J.-C. (September 2008). Circulating Concentrations of 25-Hydroxyvitamin D after a Single Oral Dose of 100.000 IU of Vitamin D2 or Vitamin D3. Journal of Bone and Mineral Research, 23, 212.

Cornez, I., Creppe, C., Gillard, M., Hennuy, B., Chapelle, J.-P., Dejardin, E., Merville, M.-P., Close, P., & Chariot, A. (June 2008). Deregulated expression of pro-survival and pro-apoptotic p53-dependent genes upon Elongator deficiency in colon cancer cells. Biochemical Pharmacology, 75, 2122-2134. doi:10.1016/j.bcp.2008.03.006

Cavalier, E., Carlisi, A., Chapelle, J.-P., & Delanaye, P. (January 2008). False positive PTH results: An easy strategy to test and detect analytical interferences in routine practice. Clinica Chimica Acta, 387 (1-2), 150-152. doi:10.1016/j.cca.2007.08.019

Cavalier, E., Delanaye, P., Morreale, A., Carlisi, I., Mourad, I., Chapelle, J.-P., & Emonts, P. (2008). La carence en vitamine d chez les femmes enceintes en region liegeoise: un probleme meconnu. Revue Médicale de Liège, 63 (2), 87-91.

Cavalier, E., Rozet, E., Dubois, N., Charlier, C., Hubert, P., Chapelle, J.-P., Krzesinski, J.-M., & Delanaye, P. (2008). Performance of iohexol determination in serum and urine by HPLC: validation, risk and uncertainty assessment. Clinica Chimica Acta, 396, 80-85. doi:10.1016/j.cca.2008.07.011

Chau, T.-L., Gioia, R., GATOT, J.-S., Patrascu, F. A., Carpentier, I., Chapelle, J.-P., O'Neill, L., Beyaert, R., Piette, J., & Chariot, A. (2008). Are the IKKs and IKK-related kinases TBK1 and IKK-ε similarly activated ? Trends in Biochemical Sciences, 33, 171-180. doi:10.1016/j.tibs.2008.01.002

Delanaye, P., Cavalier, E., Depas, G., Chapelle, J.-P., & Krzesinski, J.-M. (2008). New data on the intraindividual variation of cystatin C. Nephron. Clinical Practice, 108 (4), 246-8. doi:10.1159/000124327

Delanaye, P., Cavalier, E., Radermecker, R., Paquot, N., Depas, G., Chapelle, J.-P., Scheen, A., & Krzesinski, J.-M. (2008). Cystatin C or Creatinine for Detection of Stage 3 Chronic Kidney Disease in Anorexia Nervosa. Nephron. Clinical Practice, 110 (3), 158-c163. doi:10.1159/000166607

Delanaye, P., Cavalier, E., Saint-Remy, A., Lutteri, L., Chapelle, J.-P., & Krzesinski, J.-M. (2008). Prévalence de la maladie rénale chronique par l’estimation du DFG avec une formule basée sur la créatinine versus la cystatine C [Poster presentation]. 10ème réunion commune de la société de Néphrologie et de la société Francophone de Dialyse, Marrakech, Morocco.

Delanaye, P., Pieroni, L., Abshoff, C., Lutteri, L., Chapelle, J.-P., Krzesinski, J.-M., Hainque, B., & Cavalier, E. (2008). Analytical study of three cystatin C assays and their impact on cystatin C-based GFR-prediction equations. Clinica Chimica Acta, 398 (1-2), 118-24. doi:10.1016/j.cca.2008.09.001

Gadisseur, R., Collard, L., Cataldo, D., Chapelle, J.-P., & Cavalier, E. (2008). Can laboratory tests help to define the profile of desensitised patients or patients at high risk of severe reaction ? Allergy, 63 (Suppl. 88), 1773.

Gillery, Bordas-fonfrède, Chapelle, J.-P., Hue, & Perrier. (2008). Encore un pas vers la standardisation internationale du dosage d'HbA1c. Annales de Biologie Clinique, 66 (1), 6-8. doi:10.1684/abc.2008.0186

Hody, S., Croisier, J.-L., Wang, F.-C., Chapelle, J.-P., Rogister, B., & Leprince, P. (2008). Interest of a comparative proteomic approach to unravel the aetiology of DOMS in humans. Acta Physiologica Scandinavica. Supplementum, 194 (suppl 666), 09.

Le Goff, C., Kaux, J.-F., Chapelle, J.-P., & Lutteri, L. (January 2008). Comment j'explore... Revue des principaux auto-anticorps. Revue Médicale de Liège, 63 (1), 43-9.

Meuwis, M.-A.* , Fillet, M.* , Lutteri, L., Marée, R., Geurts, P., De Seny, D., Malaise, M., Chapelle, J.-P., Wehenkel, L., Belaiche, J., Merville, M.-P., & Louis, E. (2008). Proteomics for prediction and characterization of response to infliximab in Crohn's disease: a pilot study. Clinical Biochemistry, 41 (12), 960-7. doi:10.1016/j.clinbiochem.2008.04.021
* These authors have contributed equally to this work.

Mistretta, V., Delanaye, P., Chapelle, J.-P., Souberbielle, J.-C., & Cavalier, E. (2008). Vitamine D2 ou vitamine D3? Revue de Médecine Interne, 29 (10), 815-20. doi:10.1016/j.revmed.2008.03.003

Monfort, M., Delanaye, P., Chapelle, J.-P., & Cavalier, E. (2008). Calcium chez les patients hemodialyses : calcemie totale ou calcium ionise ? Le laboratoire doit-il systematiquement fournir au clinicien une valeur de calcemie totale corrigee obtenue par calcul ? Annales de Biologie Clinique, 66 (5), 573-6. doi:10.1684/abc.2008.0264

Piéroni, L., Delanaye, P., Abshoff, C., Lutteri, L., Chapelle, J.-P., Hainque, B., Krzesinski, J.-M., & Cavalier, E. (2008). Impact de la stabilité de la cystatine C sur la validité des mesures dans les études rétrospectives [Poster presentation]. 10ème réunion commune de la société de Néphrologie et de la société Francophone de Dialyse, Marrakech, Morocco.

Lognard, M., Cavalier, E., Chapelle, J.-P., Lambermont, B., Krzesinski, J.-M., & Delanaye, P. (19 December 2007). Acetylcysteine and Enzymatic Creatinine: Beware of Laboratory Artefact! [letter to the editor]. Intensive Care Medicine, 34 (5), 973-974. doi:10.1007/s00134-007-0972-9

Katsanos, K., Cavalier, E., Ferrante, M., Schnitzler, F., Katsaraki, A., Noman, M., Vermeire, S., Epameinondas, V. T., Rutgeerts, P., Chapelle, J.-P., & Van Assche, G. (December 2007). Intravenous iron therapy restores functional iron deficiency induced by infliximab. Journal of Crohn's and Colitis, 1, 97-105. doi:10.1016/j.crohns.2007.08.005

GATOT, J.-S., Gioia, R., Chau, T.-L., Patrascu, F. A., Warnier, M., Close, P., Chapelle, J.-P., Muraille, E., Brown, K., Siebenlist, U., Piette, J., Dejardin, E., & Chariot, A. (26 October 2007). Lipopolysaccharide-mediated interferon regulatory factor activation involves TBK1-IKK epsilon-dependent lys(63)-linked polyubiquitination and phosphorylation of TANK/I-TRAF. Journal of Biological Chemistry, 282 (43), 31131-31146. doi:10.1074/jbc.M701690200

Haleng, J., Pincemail, J., Defraigne, J.-O., Charlier, C., & Chapelle, J.-P. (October 2007). Le stress oxydant. Revue Médicale de Liège, 62 (10), 628-38.

Pincemail, J., Haleng, J., Le Goff, C., Charlier, C., Chapelle, J.-P., & Defraigne, J.-O. (2007). Stress oxydant : comment évaluer le statut du patient? Nutrition Infos, (oct/nov/déc), 47-50.

Cavalier, E., Delanaye, P., Carlisi, I., Krzesinski, J.-M., & Chapelle, J.-P. (September 2007). Impact des conditions préanalytiques sur le dosage de la PTH. Néphrologie et Thérapeutique, 3 (5), 192.

Cavalier, E., Delanaye, P., Carlisi, A., Krzesinski, J.-M., & Chapelle, J.-P. (August 2007). Stability of intact parathyroid hormone in samples from hemodialysis patients. Kidney International, 72 (3), 370-372. doi:10.1038/sj.ki.5002363

Ledoux, D., Monchi, M., Chapelle, J.-P., & Damas, P. (August 2007). Cystatin C blood level as a risk factor for death after heart surgery. European Heart Journal, 28 (15), 1848-53. doi:10.1093/eurheartj/ehm270

Cavalier, E., Delanaye, P., Carlisi, I., Krzesinski, J.-M., & Chapelle, J.-P. (June 2007). PTH stability : preanalytical conditios influences for Liaison (Diasorin). Clinical Chemistry and Laboratory Medicine, 45.

Cavalier, E., Delanaye, P., Carlisi, I., Krzesinski, J.-M., & Chapelle, J.-P. (June 2007). Evaluation of heterophile antibodies interference on Liaison PTH (Diasorin). Clinical Chemistry and Laboratory Medicine, 45.

Cavalier, E., Delanaye, P., Krzesinski, J.-M., & Chapelle, J.-P. (23 March 2007). MDRD equation for GFR estimation : analytical limitations [Paper presentation]. 10th International Symposium of Nephrology at Montecatini, Montecatini Terme, Italy.

Delanaye, P., Nellessen, E., Cavalier, E., Depas, G., Grosch, S., Defraigne, J.-O., Chapelle, J.-P., Krzesinski, J.-M., & Lancellotti, P. (15 March 2007). Is cystatin C useful for the detection and the estimation of low glomerular filtration rate in heart transplant patients? Transplantation, 83 (5), 641-644. doi:10.1097/01.tp.0000253746.30273.cd

Cavalier, E., Delanaye, P., Ferir, A.-M., Krzesinski, J.-M., & Chapelle, J.-P. (February 2007). Measurement uncertainty of creatinine in low values: Another good reason not to use the MDRD formula with low creatinine values. Clinical Biochemistry, 40 (3-4), 285-286. doi:10.1016/j.clinbiochem.2006.10.021

Cavalier, E., Delanaye, P., Carlisi, A., Krzesinski, J.-M., & Chapelle, J.-P. (2007). Analytical validation of the new version of the Liaison N-Tact PTH assay. Clinical Chemistry and Laboratory Medicine, 45 (1), 105-107. doi:10.1515/CCLM.2007.017

Delanaye, P., Cavalier, E., Depas, G., Chapelle, J.-P., & Krzesinski, J.-M. (2007). Variabilité du débit de filtration glomérulaire, de la créatinine et de la cystatine C plasmatiques [Poster presentation]. 9ème réunion commune de la société de Néphrologie et de la société Francophone de Dialyse, Lyon, France.

Gach, O., Legrand, V., Biessaux, Y., Chapelle, J.-P., Vanbelle, S., & Pierard, L. (01 January 2007). Long-term prognostic significance of high-sensitivity C-reactive protein before and after coronary angioplasty in patients with stable angina pectoris. American Journal of Cardiology, 99 (1), 31-35. doi:10.1016/j.amjcard.2006.07.059

Goffinet, J., Bernard, P., Cavalier, E., & Chapelle, J.-P. (2007). Evaluation of the new BRAHMS-Biomerieux quantitative test for procalcitonin determination. Acta Clinica Belgica, 62 (6), 463-463.

Lognard, M., Cavalier, E., Chapelle, J.-P., Lambermont, B., Krzesinski, J.-M., & Delanaye, P. (2007). Acetylcysteine and enzymatic creatinine: take care for interference! Acta Clinica Belgica, 62 (6), 462-462.

Teixeira, J., Aldenhoff, M.-C., & Chapelle, J.-P. (2007). Analytical and Clinical Evaluation of the New Tosoh G8 Analyser for HbA1c Measurement. Acta Clinica Belgica, 62-6.

Delanaye, P., Cavalier, E., Chapelle, J.-P., Krzesinski, J.-M., & Froissart, M. (November 2006). Renal extraction of cystatin C [letter to the editor]. Nephrology Dialysis Transplantation, 21 (11), 3333-3333. doi:10.1093/ndt/gfl324

Cavalier, E., Delanaye, P., Carlisi, I., Krzesinski, J.-M., & Chapelle, J.-P. (2006). PTH oxidation after a session of hemodialyze: myth or reality? Immuno-Analyse and Biologie Spécialisée.

Cavalier, E., Levaux, L., Carlisi, I., Delanaye, P., Krzesinski, J.-M., & Chapelle, J.-P. (2006). VALIDATION ANALYTIQUE DE LA TROUSSE OCTEIA 25-HYDROXYVITAMINE D (IDS). Immuno-Analyse and Biologie Spécialisée.

Cavalier, E., Delanaye, P., Collette, J., Krzesinski, J.-M., & Chapelle, J.-P. (September 2006). Evaluation of different bone markers in hemodialyzed patients. Clinica Chimica Acta, 371 (1-2), 107-111. doi:10.1016/j.cca.2006.02.029

Delanaye, P., Cavalier, E., Chapelle, J.-P., & Krzesinski, J.-M. (April 2006). Importance of the creatinine calibration in the estimation of GFR by MDRD equation [letter to the editor]. Nephrology Dialysis Transplantation, 21 (4), 1130-1130. doi:10.1093/ndt/gfl038

Bonif, M., Meuwis, M.-A., Close, P., Benoit, V., Heyninck, K., Chapelle, J.-P., Bours, V., Merville, M.-P., Piette, J., Beyaert, R., & Chariot, A. (2006). TNFa and IKKb-mediated TANK/I-TRAF phosphorylation: implications for interaction with NEMO/IKKg and NF-kB activation. Biochemical Journal, 394, 593-603. doi:10.1042/BJ20051659

Cavalier, E., Carlisi, A., & Chapelle, J.-P. (2006). Validation analytique de l'ImmunoCap 250 (Sweden Diagnostics). Annales de Biologie Clinique, 64 (1, Jan-Feb), 91-4.

Delanaye, P., Cavalier, E., Radermecker, R., Paquot, N., Depas, G., Chapelle, J.-P., & Krzesinski, J.-M. (2006). Estimation du débit de filtration glomérulaire par les formules basées sur la créatinine et la cystatine C en cas d’anorexie mentale [Paper presentation]. 8éme réunion commune de la société de Néphrologie et de la société Francophone de Dialyse, Lille, France.

Delanaye, P., Cavalier, E., Radermecker, R., Rorive, M., Depas, G., Chapelle, J.-P., & Krzesinski, J.-M. (2006). Plasma cystatin C for the detection of renal failure in obese patients [Poster presentation]. 43ème Congress of ERA-EDTA, Glasgow, United Kingdom.

Delanaye, P., Nellessen, E., Grosch, S., Depas, G., Cavalier, E., Defraigne, J.-O., Chapelle, J.-P., Krzesinski, J.-M., & Lancellotti, P. (2006). Creatinine-based formulae for the estimation of glomerular filtration rate in heart transplant recipients. Clinical Transplantation, 20 (5, Sep-Oct), 596-603. doi:10.1111/j.1399-0012.2006.00523.x

Meex, C., Poncin, J., Chapelle, J.-P., & Cavalier, E. (2006). Analytical validation of the new plasma calibrated Accu-Chek (R) Test Strips (Roche Diagnostics). Clinical Chemistry and Laboratory Medicine, 44 (11), 1376-1378. doi:10.1515/CCLM.2006.249

Cavalier, E., Delanaye, P., Krzesinski, J.-M., & Chapelle, J.-P. (2005). Comparison of liaison N-tact PTH (diasorin) and N-tact PTH SPIRMA (diasorin) in hemodialyzed patients [letter to the editor]. Clinical Chemistry and Laboratory Medicine, 43 (8), 890-891. doi:10.1515/CCLM.2005.151

Delanaye, P., Krzesinski, J.-M., & Chapelle, J.-P. (2005). Impact des différences dans les techniques de calibration de la créatinine sérique sur les résultats de la formule de Cockcroft et du MDRD [Poster presentation]. 7ème réunion commune de la Société de Néphrologie et de la société Française de Dialyse, Clermont-Ferrand, France.

Pagani, F., Stefini, F., Chapelle, J.-P., Lefevre, G., Graine, H., Luthe, H., Engelmayer, J., & Panteghini, M. (September 2004). Multicenter evaluation of analytical performance of the Liaison((R)) troponin I assay. Clinical Biochemistry, 37 (9), 750-757. doi:10.1016/j.clinbiochem.2004.04.003

Delanaye, P., Lambermont, B., Chapelle, J.-P., Gielen, J., Gérard, P., & Rorive, G. (May 2004). Plasmatic cystatin C for the estimation of glomerular filtration rate in intensive care units. Intensive Care Medicine, 30 (5), 980-983. doi:10.1007/s00134-004-2189-5

Delanaye, P., Nellessen, E., Grosch, S., Depas, G., Chapelle, J.-P., Gielen, J., Foidart, J., Krzesinski, J.-M., & Lancellotti, P. (2004). Is plasme cystatin C better than creatinine to detect renal failure in heart transplant recipients? [Paper presentation]. 41ème Congress of ERA-EDTA, Lisbonne, Portugal.

Delanaye, P., Radermecker, R., Rorive, M., Depas, G., Chapelle, J.-P., Gielen, J., & Krzesinski, J.-M. (2004). Detection of renal failure in overweight patients [Poster presentation]. Réunion de la Société Belge de Néphrologie, Liège, Belgium.

Delanaye, P., Radermecker, R., Saint-Remy, A., Chapelle, J.-P., Depas, G., Foidart, J., Gielen, J., Scheen, A., & Krzesinski, J.-M. (2004). Estimation de la fonction rénale chez le patient anorexique [Poster presentation]. Congrès annuel de l’ALFEDIAM, Nice, France.

Delanaye, P., Radermecker, R., Saint-Remy, A., Depas, G., Chapelle, J.-P., Gielen, J., Scheen, A., & Krzesinski, J.-M. (2004). Estimation of renal function in anorexia nervosa [Poster presentation]. Réunion de la Société Belge de Néphrologie, Liège, Belgium.

Delanaye, P., Saint-Remy, A., Nellessen, E., Grosch, S., Depas, G., Chapelle, J.-P., Gielen, J., Krzesinski, J.-M., & Lancellotti, P. (2004). New methods for the detection and estimation of renal function in heart transplant recipients [Paper presentation]. Meeting of the Belgian Transplantation Society, Bruxelles, Belgium.

Camus, G., Croisier, J.-L., Chapelle, J.-P., Deby-Dupont, G., Deby, C., Crielaard, J.-M., & Lamy, M. (November 2003). Activation of circulating polymorphonuclear neutrophils during exercise-induced muscle damage. Pflugers Arch – Eur J Physiol, 447, 9.

Delanaye, P., Chapelle, J.-P., Ferir, A.-M., Gielen, J.-L., Krzesinski, J.-M., & Rorive, G. (February 2003). La mesure du débit de filtration glomérulaire en clinique quotidienne. Revue Médicale de Liège, 58 (2), 95-100.

Chapelle, J.-P. (2003). Multimarker approach to risk stratification. Clinical Chemistry and Laboratory Medicine, 41, 79.

Chapelle, J.-P., Aldenhoff, M.-C., & Gielen, J. (2003). The use of the Tosoh AIA-600II and AIA-1800 immunoassay analysers for the determination of CTNI. Clinical Chemistry and Laboratory Medicine, 41, 571.

Chapelle, J.-P., Aldenhoff, M.-C., Pincemail, J., & Gielen, J. (2003). Evaluation of the nex Tosoh cardiac troponin I assay on AIA-600II. Application to myocardial damage detection in semi-marathon and triathlon runners. Clinical Chemistry and Laboratory Medicine, 41, 5414.

Delanaye, P., Chapelle, J.-P., Gielen, J., Krzesinski, J.-M., & Rorive, G. (2003). L'intérêt de la cystatine C dans l'évaluation de la fonction rénale. Nephrologie, 24 (8), 457-68.

Delanaye, P., Lambermont, B., Chapelle, J.-P., Gielen, J., & Rorive, G. (2003). Intérêt de la cystatine C dans l’évaluation de la fonction rénale chez le patient hospitalisé aux soins intensifs [Poster presentation]. 31ème congrès de la Société de Réanimation de Langue Française, Paris, France.

Goffinet, J., Bodson, Q., Chapelle, J.-P., Gielen, J., & Ferir, A. M. (2003). Influence of Hyperbilirubinemia on Spectrophotometric Measurement of 30 Biochemical Tests, using the Roche® Modular P-module. Clinical Chemistry and Laboratory Medicine, 41, 88-89.

Chapelle, J.-P. (2001). Clinical applications of cardiac troponins. Acta Clinica Belgica, 56, 323.

Chapelle, J.-P. (2001). Are cardiac markers useful in patients with chronic renal failure? Clinical Chemistry and Laboratory Medicine, 39 (suppl), 36.

Chapelle, J.-P., Legrand, V., Lutteri, L., & Gielen, J. (2001). Cardiac troponin I and T concentrations are related to plasma lipoprotein (a) levels in PTCA patients. European Heart Journal, 22, 209.

Lutteri, L., Legrand, V., Gielen, J., & Chapelle, J.-P. (2001). Relationship between lipoprotein (a) and cardiac troponins in PTCA patients. Acta Clinica Belgica, 56, 325.

Lutteri, L., Legrand, V., Gielen, J., & Chapelle, J.-P. (2001). Association between lipoprotein (A) and cardiac troponins in PTCA patients. Clinical Chemistry and Laboratory Medicine, 39 (suppl), 278.

Pincemail, J., Bovy, C., Chapelle, J.-P., Gielen, J., Defraigne, J., & Rorive, G. (2001). Markers of oxidative stress limited to increased risk of cardiovascular disease in chronic hemodialysis patients. Free Radical Biology and Medicine, 31 (suppl), 345.

Servais, P., Nys, M., Canivet, J.-L., Ledoux, D., Monchi, M., Chapelle, J.-P., & Damas, P. (2001). Relationship between procalcitonin plasma level and severity of infection. Intensive Care Medicine, 27 (suppl.), 560.

Chapelle, J.-P., Aldenhoff, M.-C., Pierard, L., & Gielen, J. (November 2000). Comparison of cardiac troponin I measurements on whole blood and plasma on the Stratus CS analyzer and comparison with AxSYM. Clinical Chemistry, 46 (11), 1864-6. doi:10.1093/clinchem/46.11.1864

Gillery, P., Hue, G., Bordas-Fonfrède, M., Chapelle, J.-P., Drouin, P., Lévy-Marchal, C., Périer, C., Sélam, J.-L., Thivolet, C., & Vialettes, B. (August 2000). Dosage de l'hémoglobine A1C et hémoglobinopathies : problèmes posés et conduite à tenir. Annales de Biologie Clinique, 58 (4), 425-9.

Chapelle, J.-P., Aldenhoff, M.-C., Pierard, L., & Gielen, J. (2000). Comparison of the stratus CS and Axsym analysers for determination of cardiac troponin I in plasma. Acta Clinica Belgica. Supplementum, (suppl.1), 14.

Chapelle, J.-P., Biessaux, Y., Legrand, V., & Gielen, J. (2000). Prognostic significance of increased baseline plasma troponin I levels in PTCA patients. Heart, 83 (suppl. II), 24.

Chapelle, J.-P., Legrand, V., & Gielen, J. (2000). Prognostic significance of increased baseline plasma troponin I levels in PTCA patients. Clinical Chemistry, 46 (suppl), 82.

Pincemail, J., Siquet, J., Chapelle, J.-P., Cheramy-Bien, J.-P., Paulissen, G., Chantillon, A.-M., Christiaens, G., Gielen, J., Limet, R., & Defraigne, J.-O. (2000). Evaluation des concentrations plasmatiques en anti-oxydants, anticorps contre les LDL oxydees et homocysteine dans un echantillon de la population liegeoise. Annales de Biologie Clinique, 58 (2, Mar-Apr), 177-85.

Gillery, P., Bordas-Fonfrède, M., Chapelle, J.-P., Drouin, P., Hue, G., Levy-Marchal, C., Périer, C., Sélam, J. L., Slama, G., Thivolet, C., & Vialettes, B. (September 1999). HBA1c: clinical and biological agreement for standardization of assay methode. Report by the expert of ALFEDIAM (Association de Langue française pour l'étude du diabète et des maladies métaboliques) and SFBC (Société française de Biologie clinique). Diabète et Métabolisme, 25 (3), 283-7.

Pelsers, M. M., Chapelle, J.-P., Knapen, M., Vermeer, C., Muijtjens, A. M., Hermens, W. T., & Glatz, J. F. (March 1999). Influence of age and sex and day-to-day and within-day biological variation on plasma concentrations of fatty acid-binding protein and myoglobin in healthy subjects. Clinical Chemistry, 45 (3), 441-3.

Chapelle, J.-P., Gielen, J., Legrand, V., & Lutteri, L. (1999). Determination of total homocysteine in plasma by automated fluorescence polarization immunoassay. Clinical Chemistry and Laboratory Medicine, 37 (suppl), 373.

Chapelle, J.-P., Lutteri, L., & Gielen, J. (1999). Evaluation of the homocysteine assay on the Abbott IMx. Clinical Chemistry, 45 (6), 134.

Lutteri, L., Chapelle, J.-P., & Gielen, J. (1999). An association demonstrated between homocysteine, CRP and troponin levels in PTCA patients. Acta Clinica Belgica. Supplementum, (suppl.1), 15.

Gillery, P., Bordas-Fonfrède, M., Chapelle, J.-P., Hue, G., & Périer, C. (1998). Hémoglobine glyquée : le temps de la standardisation est venu. Annales de Biologie Clinique, 56 (3), 249-51.

Marechal, P., Legrand, V., Chapelle, J.-P., & Kulbertus, H. (1998). The clinical signification of troponin T, troponin I, CK and CK-MB after coronary angioplsaty. Acta Cardiologica, 53, 319.

Chapelle, J.-P., Duvivier, J., & Gielen, J. (1995). Prognostic markers in malignant diseases. Scandinavian Journal of Clinical and Laboratory Investigation. Supplementum, 55, 223.

Chapelle, J.-P., Spronck, T., & Ferir, A.-M. (1995). Analytical and clinical evaluation of automated immunoassays for serum CK-MB and myoglobin using the OPUS MAGNUM analyser. Clinical Chemistry, 41, 72.

Delanghe, J. R., Chapelle, J.-P., & Vanderschueren, S. C. (September 1990). Quantitative nephelometric assay for determining myoglobin evaluated. Clinical Chemistry, 36 (9), 1675-8. doi:10.1093/clinchem/36.9.1675

Chapelle, J.-P., & El Allaf, M. (January 1990). Automated quantification of creatinine kinase MB isoenzyme in serum by radial partition immunoassay, with use of the Stratus analyzer. Clinical Chemistry, 36 (1), 99-101. doi:10.1093/clinchem/36.1.99

el Allaf, M., Chapelle, J.-P., El Allaf, D., Adam, A., Faymonville, M.-E., Laurent, P., & Heusghem, C. (February 1986). Differentiating muscle damage from myocardial injury by meaans of the serum creatinine kinase (CK) isoenzyme MB mass measurement/total CK activity ratio. Clinical Chemistry, 32 (2), 291-5.

Albert, A., Harris, E. K., CHAPELLE, J.-P., Heusghem, C., & Kulbertus, H. (January 1984). On the interpretation of serial laboratory measurements in acute myocardial infarction. Clinical Chemistry, 30 (1), 69-76. doi:10.1093/clinchem/30.1.69

Chapelle, J.-P., & Heusghem, C. (March 1980). Further heterogeneity demonstarted for serum creatine kinase isoenzyme MM. Clinical Chemistry, 26 (3), 457-62.